Company intelligence / Profile preview

Imperial Ginseng Products

Vancouver, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Imperial Ginseng Products Ltd. was a Canada-based agricultural company that cultivated, processed, and distributed North American ginseng, almost exclusively to wholesalers in China. The company ceased operations in its original business in 2023 due to economic and labor challenges and is currently in the process of winding up. While it aimed to transition into a mining issuer, as of early 2025, it has no active business operations in healthcare or life sciences and no active drug development or clinical pipeline.

Modalities: Botanical extract
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Imperial Ginseng Products.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imperial Ginseng Products.

Explore the full profile